Company record
A clear public starting point.
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.
Startup in Sahin’s portfolio

Building radical software tools to advance the science of genomics.
| Round | Raised | Date |
|---|---|---|
| Series C | $200M | 2025 |
| Series C | $120M | 2025 |
Total raised: $435MCompany value: Valued at $10.3B
As an angel investor in 234+ startups across 37 markets, I look for companies with exceptional founders, large addressable markets, and clear competitive advantages. Colossal stood out in the Biotech space.
Company record
This page gathers the company’s published description, taxonomy, status, and official link in one place. It does not make claims about private activity or deal terms.